Anita Afzali, MD, MPH, MHCM, FACG, AGAF / Jessica R. Allegretti, MD, MPH, FACG, AGAF / Millie D. Long, MD, MPH - At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition
About this episode
The episode discusses the intersection of inflammation and fibrosis in inflammatory bowel disease and the potential of TL1A inhibition.
This content has been developed for healthcare professionals only. Patients who seek health information should consult with their physician or relevant patient advocacy groups. For the full presentation, downloadable Practice Aids, slides, and complete CME/AAPA/IPCE information, and to apply for credit, please visit us at PeerView.com/HRC865. CME/AAPA/IPCE credit will be available until June 3, 2027. At the Crossroads of Inflammation and Fibrosis in Inflammatory Bowel Disease: The Promise of TL1A Inhibition In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Support This activity is supported through an independent educational grant from Merck & Co., Inc., Rahway, NJ, USA. Disclosure information is available at the beginning of the video presentation.
Sponsors
Merck & Co., Inc.
More episodes of PeerView Clinical Pharmacology CME/CNE/CPE Video
- Andrew Kuykendall, MD - Ironing Out the Challenges of PV: Spotlight on Targeting the Hepcidin Pathway for Addressing Unmet Needs and Enhancing Patient Outcomes
- Brendon M. Stiles, MD - The Immunotherapy Playbook for Resectable NSCLC: Real-World Challenges and Practical Strategies
- Luke Maese, DO, Rachel Rau, MD - ADAPT to Advance in ALL/LBL: Achieving Durable Asparaginase Exposure With Personalized Treatment in Pediatric and AYA Patients
- Charise Gleason, MSN, NP-C, AOCNP / Beth Faiman, PhD, MSN, APN-BC, AOCN, BMTCN, FAAN, FAPO - “Off-the-Shelf” Choices in RRMM: Oncology Nurse Guidance on Delivering Quality Care With BCMA and Non-BCMA Immunotherapy
- Jaume Capdevila, MD, PhD - Propelling Modern Interventions in Neuroendocrine Carcinoma: Multidisciplinary Principles to Effectively Implement Emerging DLL3-Directed BiTE Therapy in Community Settings
- Anna Chodos, MD, MPH - Getting Ahead of Cognitive Decline—Applying Patient-Centered Strategies to Assess and Reduce Dementia Risk in Primary Care: An AI-Guided Case Simulation Activity
Explore listener stats, chart rankings, contacts and more on the PeerView Clinical Pharmacology CME/CNE/CPE Video podcast page.